Epigenetic Reprogramming: A Possible Etiological Factor in Bladder Pain Syndrome/Interstitial Cystitis?

Journal of Urology

Volumn 181, Issue 3, 2009, Pages 980-984

  Elgavish, Ada ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

cystitis; epigenesis; genetic; interstitial; urinary bladder

Indexed keywords

ENZYME; HISTONE H3; JMJD3; LIPOPOLYSACCHARIDE; LYSINE DERIVATIVE; METHYLATING LYSINE 27 HISTONE H3; POLYCOMB GROUP PROTEIN; UNCLASSIFIED DRUG;

ADULT; APICAL MEMBRANE; BASEMENT MEMBRANE; BLADDER; BLADDER EPITHELIUM; BLADDER FUNCTION; BLADDER PAIN SYNDROME; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CYSTALGIA; DATA BASE; EPIGENETICS; GENE REPRESSION; GENE SILENCING; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; INFLAMMATION; INTERSTITIAL CYSTITIS; NERVOUS SYSTEM; NEUROGENIC INFLAMMATION; NOCICEPTIVE STIMULATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN METHYLATION; REGULATORY MECHANISM; REVIEW; SENSORY STIMULATION; SIGNAL TRANSDUCTION; STEM CELL; STIMULATION;

CYSTITIS, INTERSTITIAL; EPIGENESIS, GENETIC; HUMANS;

EID: 59349102792     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.10.145     Document Type: Review

References (43)

1. Parsons J., and Parsons C.L. The historical origins of interstitial cystitis. J Urol 171 (2004) 20
2. Wein A.J., Hanno P., and Gillenwater J. Interstitial cystitis: an introduction to the problem. In: Hanno P., Staskin D.R., Krane R.J., and Wein A.J. (Eds). Interstitial Cystitis (1990), Springer Verlag, London
3. Hanno P., Nordling J., and van Ophoven A. What is new in bladder pain syndrome/interstitial cystitis?. Curr Opin Urol 18 (2008) 353
4. van de Merwe J., Nordling J., Bouchelouche P., Bouchelouche K., Cervigni M., Daha L.K., et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53 (2008) 60
5. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49 suppl. (1997) 14
6. Warren J.W. Interstitial cystitis as an infectious disease. Urol Clin North Am 21 (1994) 31
7. Anderson J., Parivar F., Lee G., Wallington T.B., MacIver A.G., Bradbrook R.A., et al. The enigma of IC-an autoimmune disease?. Br J Urol 63 (1989) 58
8. Parsons C. The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology 69 suppl. (2007) 9
9. Teichman J., and Moldwin R. The role of bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol 14 (2007) 3599
10. Sant G., Kempuraj D., Marchand J.E., and Theoharides T.C. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69 suppl. (2007) 34
11. Nazif O., Teichman J.M.H., and Gebhart G.F. Neural upregulation in interstitial cystitis. Urology 69 suppl. (2007) 24
12. Saban M.R., Nguyen N.B., Hammond T.G., and Saban R. Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P and antigen stimulation. Am J Pathol 160 (2002) 2095
13. Elgavish A., Lloyd K., and Reed R. A subpopulation of human urothelial cells is stimulated to proliferate by treatment in vitro with lipoteichoic acid, a cell wall component of Streptococcus faecalis. J Cell Physiol 169 (1996) 42
14. Elgavish A., Pattanaik A., Couchman J., Woods A., Lloyd K., Lindsey J.R., et al. Long-term treatment with lipoteichoic acid from Streptococcus faecalis affects differentiation, and expression and cellular distribution of beta 1 integrins in human urothelial cells. J Cell Physiol 169 (1996) 52
15. Elgavish A., Robert B., Lloyd K., and Reed R. Nitric oxide mediates the action of lipoteichoic acid on the function of human urothelial cells. J Cell Physiol 169 (1996) 66
16. Elgavish A. NF-kB activation mediates the response of a subpopulation of basal uroepithelial cells to a cell wall component of Enterococcus faecalis. J Cell Physiol 182 (2000) 232
17. Apodaca G., Balestreire E., and Birder L.A. The uroepithelial-associated sensory web. Kidney Int 72 (2007) 1057
18. Everaerts W., Gevaert T., Nilius B., and De Ridder D. On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn 27 (2008) 264
19. Brading A., and McCloskey K.D. Mechanisms of disease: specialized interstitial cells of the urothelium: an assessment of current knowledge. Nat Clin Pract Urol 2 (2005) 546
20. Birder L. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol 289 (2005) F489
21. Saban M.R., Hellmich H., Nguyen N.B., Winston J., Hammond T.G., and Saban R. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 5 (2001) 147
22. Okragly A., Niles A.L., Saban R., Schmidt D., Hoffman R.L., Warner T.F., et al. Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 161 (1999) 438
23. Aronson M., Medalia O., Amichay D., and Nativ O. Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun 56 (1988) 1615
24. Mulvey M., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282 (1998) 1494
25. Elliott T.S., Reed L., Slack R.C., and Bishop M.C. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect 11 (1985) 191
26. Morrison S., Shah N.M., and Anderson D.J. Regulatory mechanisms in stem cell biology. Cell 88 (1997) 287
27. Elgavish A. A hypothesis for the etiology of interstitial cystitis. In: Atala A., and Slade D. (Eds). Bladder Diseases: Research Concepts and Clinical Applications (2003), Kluwer Academic/Plenum Publishers, New York 683-712 chapt 43
28. Ito T., Ueda T., Homma Y., and Takei M. Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int J Urol 14 (2007) 1068
29. Elgavish A., Pattanaik A., Lloyd K., and Reed R. Evidence for altered proliferative ability of progenitors of of urothelial cells in interstitial cystitis. J Urol 158 (1997) 248
30. Molofsky A., Pardal R., and Morrison S.J. Diverse mechanisms regulate stem cell self-renewal. Curr Opin Cell Biol 16 (2004) 700
31. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 suppl. (2003) 245
32. Saldanha S.N., Nandakumar V., Elgavish A., and Tollefsbol T.O. Dietary and environmental influences on histone modifications in cancer. In: Tollefsbol T. (Ed). Cancer Epigenetics (2008), CRC Press, New York
33. Orlando V. Polycomb, epigenomes, and control of cell identity. Cell 112 (2003) 599
34. Jepsen K., Solum D., Zhou T., McEvilly R.J., Kim H.J., Glass C.K., et al. SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450 (2007) 415
35. De Santa F., Totaro M.G., Prosperini E., Notarbartolo S., Testa G., and Natoli G. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130 (2007) 1083
36. Bracken A., Dietrich N., Pasini D., Hansen K.H., and Helin K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev 20 (2006) 1123
37. Surani M., Hayashi K., and Hajkova P. Genetic and epigenetic regulators of pluripotency. Cell 128 (2007) 747
38. Jones R. Reversing the 'irreversible'. Nature 450 (2007) 357
39. Swigut T., and Wycocka J. H3K27 demethylases, at long last. Cell 131 (2007) 29
40. Okita K., Ichisaka T., and Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448 (2007) 313
41. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., et al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 (2007) 318
42. The AACR Human Epigenome Task Force and European Union, Network of Excellence, Scientific Advisory Board. Moving AHEAD with an international human epigenome project. Nature 454 (2008) 711
43. Egger G., Liang G., Aparicio A., and Jones P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 (2004) 457